Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Clinical Laboratory Management(Electronic Edition) ›› 2018, Vol. 06 ›› Issue (04): 226-228. doi: 10.3877/cma.j.issn.2095-5820.2018.04.008

Special Issue:

• Clinical Research • Previous Articles     Next Articles

Preparation and stability of mixed quality control products in autoantibody immunofluorescence program

Di Zhang1, Hang Yuan1, Peng Cao1, Lingzhi Xia1, Xuemei Li1, Cuihua Wang1, Yuan Mao1,()   

  1. 1. Nanjing KingMed Clinical Laboratory, Nanjing 210042, China
  • Received:2018-09-30 Online:2018-11-28 Published:2018-11-28
  • Contact: Yuan Mao
  • About author:
    Corresponding author: Mao Yuan, Email:

Abstract:

Objective

To study the appropriate proportion of self-mixing and mixed quality control products on the immunofluorescence project and evaluate its stability as to ensure an effective quality control of the corresponding indirect immunofluorescence (IIF) detection project in our laboratory.

Methods

By use of the lab-collected antinuclear antibodies (ANA), antimitochondrial antibody (AMA), antikeratin antibodies (AKA) and antineutrophil cytoplasm antibodies (p-ANCA) of each individual strong positive serum, the serum was then mixed in appropriate proportion and the weakly positive 4-item composite quality control was made for testing.

Results

AKA could not be mixed into weakly positive quality control products due to mixed interference. ANA, AMA, p-ANCA and negative serum could be configured into weakly positive quality control products according to the proportion of 1:1:1.5:3, and the stable time could be up to 20 weeks.

Conclusions

Not all autoantibodies are suitable for the preparation of mixed quality control products. The three weakly positive autoantibodies (ANA, AMA and p-ANCA) of the self-made fluorescent immunoassay have good stability and can be used for daily quality control in clinical laboratories.

Key words: Composite quality control material, Indirect immunofluorescence, Stability, Mixed interference

京ICP 备07035254号-20
Copyright © Chinese Journal of Clinical Laboratory Management(Electronic Edition), All Rights Reserved.
Tel: 020-81340564;020-37103504 Fax: 020-37103505 E-mail: clinlab@cma.org.cn
Powered by Beijing Magtech Co. Ltd